Back

Assessment of the microvascular resistance reserve for predicting the effect of revascularization in patients with moderate coronary stenoses.

1 September 2024 (17:30 - 17:45)
Organised by: Logo
Congress Presentation Part of: Smaller trials, trial updates, and other studies on coronary artery disease and coronary revascularisation Intracoronary Flow and Pressure Measurements ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Laust Dupont Rasmussen

Regional Hospital Godstrup, Herning (Denmark)

3 More presentations in this session

Presentation thumbnail
Long-term effect of biodegradable versus durable polymer drug-eluting stents on neoatherosclerosis among STEMI patients: the international CONNECT randomized controlled intracoronary OCT trial
Doctor J. Haener (Bern, CH)
Slides Video
Presentation thumbnail
Glycoprotein IIb/IIIa Inhibitors in patients with acute myocardial infarction and angiographic no-reflow: the randomized REVERSE-FLOW trial
Professor I. Eitel (Luebeck, DE)
Slides Video
Presentation thumbnail
Evaluation of ambulatory electrocardiographic monitoring of patients after high-risk acute coronary syndrome. A randomized trial.
Doctor J. De La Torre Hernandez (Santander, ES)
Slides Video

Access the full session

Session thumbnail
Smaller trials, trial updates, and other studies on coronary artery disease and coronary revascularisation
Video

The Event

Event poster

ESC Congress 2024

1 September 2024 17:30 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic implications of microvascular resistance reserve in symptomatic patients with intermediate coronary stenosis
thumbnail
Congress Presentation
Advancing prognostic insights in STEMI patients through microvascular resistance reserve evaluation
thumbnail
Congress Session
Coronary physiology and microcirculatory assessment

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources